Literature DB >> 34043433

Understanding Treatment Tolerability in Older Adults With Cancer.

Marie A Flannery1, Eva Culakova2, Beverly E Canin3, Luke Peppone2, Erika Ramsdale4, Supriya G Mohile4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34043433      PMCID： PMC8238902          DOI： 10.1200/JCO.21.00195

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  93 in total

1.  End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position article.

Authors:  Hans Wildiers; Murielle Mauer; Athanasios Pallis; Arti Hurria; Supriya G Mohile; Andrea Luciani; Giuseppe Curigliano; Martine Extermann; Stuart M Lichtman; Karla Ballman; Harvey Jay Cohen; Hyman Muss; Ulrich Wedding
Journal:  J Clin Oncol       Date:  2013-09-09       Impact factor: 44.544

2.  Validity and reliability of the FACT-G scale for use in the older person with cancer.

Authors:  J Overcash; M Extermann; J Parr; J Perry; L Balducci
Journal:  Am J Clin Oncol       Date:  2001-12       Impact factor: 2.339

3.  Treatment Satisfaction of Patients With Advanced Non-Small-cell Lung Cancer Receiving Platinum-based Chemotherapy: Results From a Prospective Cohort Study (PERSONAL).

Authors:  Sabine Visser; Mark de Mol; Kiki Cheung; Jermo J van Toor; Nico C van Walree; Bruno H Stricker; Brenda L Den Oudsten; Joachim G J V Aerts
Journal:  Clin Lung Cancer       Date:  2018-03-17       Impact factor: 4.785

4.  Trans sectoral care of geriatric cancer patients based on comprehensive geriatric assessment and patient-reported quality of life - Results of a multicenter study to develop and pilot test a patient-centered interdisciplinary care concept for geriatric oncology patients (PIVOG).

Authors:  Heike Schmidt; Stephanie Boese; Katharina Lampe; Karin Jordan; Eckhard Fiedler; Ursula Müller-Werdan; Andreas Wienke; Dirk Vordermark
Journal:  J Geriatr Oncol       Date:  2017-05-19       Impact factor: 3.599

5.  The underreporting of phase III chemo-therapeutic clinical trial data of older patients with cancer: A systematic review.

Authors:  Karlynn BrintzenhofeSzoc; Jessica L Krok-Schoen; Beverly Canin; Ira Parker; Amy R MacKenzie; Thuy Koll; Ritika Vankina; Christine D Hsu; Brian Jang; Kathy Pan; Jennifer L Lund; Edith Starbuck; Armin Shahrokni
Journal:  J Geriatr Oncol       Date:  2020-01-10       Impact factor: 3.599

6.  Use of PRO Measures to Inform Tolerability in Oncology Trials: Implications for Clinical Review, IND Safety Reporting, and Clinical Site Inspections.

Authors:  Janice Kim; Harpreet Singh; Kassa Ayalew; Kristina Borror; Michelle Campbell; Laura Lee Johnson; Alyson Karesh; Ni A Khin; Joanne R Less; Jerry Menikoff; Lori Minasian; Sandra A Mitchell; Elektra J Papadopoulos; Richard L Piekarz; Kevin A Prohaska; Susan Thompson; Rajeshwari Sridhara; Richard Pazdur; Paul G Kluetz
Journal:  Clin Cancer Res       Date:  2017-12-13       Impact factor: 12.531

7.  Future of cancer incidence in the United States: burdens upon an aging, changing nation.

Authors:  Benjamin D Smith; Grace L Smith; Arti Hurria; Gabriel N Hortobagyi; Thomas A Buchholz
Journal:  J Clin Oncol       Date:  2009-04-29       Impact factor: 44.544

8.  Treatment patterns, risk for hospitalization and mortality in older patients with triple negative breast cancer.

Authors:  Antonis Valachis; Pontus Nyström; Irma Fredriksson; Anna-Karin Wennstig; Johan Ahlgren
Journal:  J Geriatr Oncol       Date:  2020-09-12       Impact factor: 3.599

9.  Establishing a common metric for patient-reported outcomes in cancer patients: linking patient reported outcomes measurement information system (PROMIS), numerical rating scale, and patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE).

Authors:  Minji K Lee; Benjamin D Schalet; David Cella; Kathleen J Yost; Amy C Dueck; Paul J Novotny; Jeff A Sloan
Journal:  J Patient Rep Outcomes       Date:  2020-12-10

10.  Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index.

Authors:  Gillian Gresham; Márcio A Diniz; Zahra S Razaee; Michael Luu; Sungjin Kim; Ron D Hays; Steven Piantadosi; Mourad Tighiouart; Greg Yothers; Patricia A Ganz; André Rogatko
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506
View more
  5 in total

1.  Overview of Sankey flow diagrams: Focusing on symptom trajectories in older adults with advanced cancer.

Authors:  Ethan Otto; Eva Culakova; Sixu Meng; Zhihong Zhang; Huiwen Xu; Supriya Mohile; Marie A Flannery
Journal:  J Geriatr Oncol       Date:  2022-01-07       Impact factor: 3.929

2.  Is adjuvant chemotherapy necessary in older patients with breast cancer?

Authors:  Midori Morita; Akihiko Shimomura; Emi Tokuda; Yoshiya Horimoto; Yukino Kawamura; Yumiko Ishizuka; Katsutoshi Sekine; Sayaka Obayashi; Yuki Kojima; Yukari Uemura; Toru Higuchi
Journal:  Breast Cancer       Date:  2022-01-15       Impact factor: 3.307

3.  Tolerance to oral anticancer agent treatment in older adults with cancer: a secondary analysis of data from electronic health records and a pilot study of patient-reported outcomes.

Authors:  Yun Jiang; Madilyn Mason; Youmin Cho; Ankita Chittiprolu; Xingyu Zhang; Karen Harden; Yang Gong; Marcelline R Harris; Debra L Barton
Journal:  BMC Cancer       Date:  2022-09-03       Impact factor: 4.638

4.  Using the alluvial plot to visualize the network characteristics of 100 top-cited articles on attention-deficit/hyperactivity disorder (ADHD) since 2011: Bibliometric analysis.

Authors:  Ya-Ching Tsai; Tsair-Wei Chien; Jian-Wei Wu; Chien-Ho Lin
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

Review 5.  Radiotherapy for Newly Diagnosed Glioblastoma in the Elderly: What Is the Standard?

Authors:  Chan Woo Wee
Journal:  Brain Tumor Res Treat       Date:  2022-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.